Sulbutiamine
As of the edition of 20 October 2026, Sulbutiamine is a small molecule: marketed, first approved in 1982 (ES).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1996
- Kind
- Small molecule
- Brand name
- Surmenalit
- First approved
- 1 November 1982 (ES)
- Approvals on record
- 3 in 3 regions
- Holder of the most recent approval
- Servier; 3 holders in all
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.